APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol and Ciprofol Injections

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Propofol and Ciprofol Injections Market Analysis and Forecast 2026-2032

22 December 2025206 pages

Choose your research edition.

Industry ResearchPropofol and Ciprofol Injections Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol and Ciprofol Injections Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Propofol and Ciprofol Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol and Ciprofol Injections Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol and Ciprofol Injections Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Propofol and Ciprofol Injections market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Propofol and Ciprofol Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Propofol and Ciprofol Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Propofol and Ciprofol Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Propofol and Ciprofol Injections is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Propofol and Ciprofol Injections include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Haisco Pharmaceutical Group, Jiangsu Yingke Biopharmaceutical, Pfizer, Guangdong Jiabo Pharmaceutical, Fresenius Kabi, Jiangsu Nhwa Pharmaceutical and B. Braun, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Propofol and Ciprofol Injections, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Propofol and Ciprofol Injections, also provides the sales of main regions and countries. Of the upcoming market potential for Propofol and Ciprofol Injections, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Propofol and Ciprofol Injections sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Propofol and Ciprofol Injections market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Propofol and Ciprofol Injections sales, projected growth trends, production technology, application and end-user industry.

Propofol and Ciprofol Injections Segment by Company

Xi’an Libang Pharmaceutical

Sichuan Kelun Pharmaceutical

Haisco Pharmaceutical Group

Jiangsu Yingke Biopharmaceutical

Pfizer

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Jiangsu Nhwa Pharmaceutical

B. Braun

Beijing Sciecure Pharmaceutical

Sichuan Biokin Pharmaceutical

AstraZeneca

Wellona Pharma

Rusoma

NEON

Flagship Biotech

Dr. Reddy's Laboratories

Centurion Healthcare

Propofol and Ciprofol Injections Segment by Type

Propofol Injections

Ciprofol Injections

Propofol and Ciprofol Injections Segment by Application

Gastrointestinal Endoscopy

Anesthesia for Surgery

Other

Propofol and Ciprofol Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol and Ciprofol Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol and Ciprofol Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol and Ciprofol Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Propofol and Ciprofol Injections in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Propofol and Ciprofol Injections manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Propofol and Ciprofol Injections sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Propofol and Ciprofol Injections Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Propofol Injections Major Manufacturers Table 3. Ciprofol Injections Major Manufacturers Table 4. Global Propofol and Ciprofol Injections Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Gastrointestinal Endoscopy Major Manufacturers Table 6. Anesthesia for Surgery Major Manufacturers Table 7. Other Major Manufacturers Table 8. Propofol and Ciprofol Injections Industry Trends Table 9. Propofol and Ciprofol Injections Industry Drivers Table 10. Propofol and Ciprofol Injections Industry Opportunities and Challenges Table 11. Propofol and Ciprofol Injections Industry Restraints Table 12. Global Propofol and Ciprofol Injections Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Propofol and Ciprofol Injections Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Propofol and Ciprofol Injections Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2026) Table 16. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2027-2032) Table 17. Global Propofol and Ciprofol Injections Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Propofol and Ciprofol Injections Sales by Region (2021-2026) & (k units) Table 19. Global Propofol and Ciprofol Injections Sales by Region (2027-2032) & (k units) Table 20. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2026) Table 21. Global Propofol and Ciprofol Injections Sales Market Share by Region (2027-2032) Table 22. Global Propofol and Ciprofol Injections Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Propofol and Ciprofol Injections Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Propofol and Ciprofol Injections Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers (2021-2026) Table 26. Global Propofol and Ciprofol Injections Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Propofol and Ciprofol Injections Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Propofol and Ciprofol Injections Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Propofol and Ciprofol Injections Manufacturers, Product Type & Application Table 30. Global Propofol and Ciprofol Injections Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Propofol and Ciprofol Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Propofol and Ciprofol Injections Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2026) Table 37. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2027-2032) Table 38. Global Propofol and Ciprofol Injections Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 40. Global Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 41. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2026) Table 42. Global Propofol and Ciprofol Injections Sales Market Share by Type (2027-2032) Table 43. Global Propofol and Ciprofol Injections Price by Type (2021-2026) & (US$/unit) Table 44. Global Propofol and Ciprofol Injections Price by Type (2027-2032) & (US$/unit) Table 45. Global Propofol and Ciprofol Injections Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2026) Table 49. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2027-2032) Table 50. Global Propofol and Ciprofol Injections Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 52. Global Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 53. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2026) Table 54. Global Propofol and Ciprofol Injections Sales Market Share by Application (2027-2032) Table 55. Global Propofol and Ciprofol Injections Price by Application (2021-2026) & (US$/unit) Table 56. Global Propofol and Ciprofol Injections Price by Application (2027-2032) & (US$/unit) Table 57. Xi’an Libang Pharmaceutical Company Information Table 58. Xi’an Libang Pharmaceutical Business Overview Table 59. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 61. Xi’an Libang Pharmaceutical Recent Development Table 62. Sichuan Kelun Pharmaceutical Company Information Table 63. Sichuan Kelun Pharmaceutical Business Overview Table 64. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 66. Sichuan Kelun Pharmaceutical Recent Development Table 67. Haisco Pharmaceutical Group Company Information Table 68. Haisco Pharmaceutical Group Business Overview Table 69. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio Table 71. Haisco Pharmaceutical Group Recent Development Table 72. Jiangsu Yingke Biopharmaceutical Company Information Table 73. Jiangsu Yingke Biopharmaceutical Business Overview Table 74. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 76. Jiangsu Yingke Biopharmaceutical Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Pfizer Propofol and Ciprofol Injections Product Portfolio Table 81. Pfizer Recent Development Table 82. Guangdong Jiabo Pharmaceutical Company Information Table 83. Guangdong Jiabo Pharmaceutical Business Overview Table 84. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 86. Guangdong Jiabo Pharmaceutical Recent Development Table 87. Fresenius Kabi Company Information Table 88. Fresenius Kabi Business Overview Table 89. Fresenius Kabi Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio Table 91. Fresenius Kabi Recent Development Table 92. Jiangsu Nhwa Pharmaceutical Company Information Table 93. Jiangsu Nhwa Pharmaceutical Business Overview Table 94. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 96. Jiangsu Nhwa Pharmaceutical Recent Development Table 97. B. Braun Company Information Table 98. B. Braun Business Overview Table 99. B. Braun Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. B. Braun Propofol and Ciprofol Injections Product Portfolio Table 101. B. Braun Recent Development Table 102. Beijing Sciecure Pharmaceutical Company Information Table 103. Beijing Sciecure Pharmaceutical Business Overview Table 104. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 106. Beijing Sciecure Pharmaceutical Recent Development Table 107. Sichuan Biokin Pharmaceutical Company Information Table 108. Sichuan Biokin Pharmaceutical Business Overview Table 109. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio Table 111. Sichuan Biokin Pharmaceutical Recent Development Table 112. AstraZeneca Company Information Table 113. AstraZeneca Business Overview Table 114. AstraZeneca Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. AstraZeneca Propofol and Ciprofol Injections Product Portfolio Table 116. AstraZeneca Recent Development Table 117. Wellona Pharma Company Information Table 118. Wellona Pharma Business Overview Table 119. Wellona Pharma Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Wellona Pharma Propofol and Ciprofol Injections Product Portfolio Table 121. Wellona Pharma Recent Development Table 122. Rusoma Company Information Table 123. Rusoma Business Overview Table 124. Rusoma Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Rusoma Propofol and Ciprofol Injections Product Portfolio Table 126. Rusoma Recent Development Table 127. NEON Company Information Table 128. NEON Business Overview Table 129. NEON Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. NEON Propofol and Ciprofol Injections Product Portfolio Table 131. NEON Recent Development Table 132. Flagship Biotech Company Information Table 133. Flagship Biotech Business Overview Table 134. Flagship Biotech Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Flagship Biotech Propofol and Ciprofol Injections Product Portfolio Table 136. Flagship Biotech Recent Development Table 137. Dr. Reddy's Laboratories Company Information Table 138. Dr. Reddy's Laboratories Business Overview Table 139. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio Table 141. Dr. Reddy's Laboratories Recent Development Table 142. Centurion Healthcare Company Information Table 143. Centurion Healthcare Business Overview Table 144. Centurion Healthcare Propofol and Ciprofol Injections Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio Table 146. Centurion Healthcare Recent Development Table 147. North America Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 150. North America Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 151. North America Propofol and Ciprofol Injections Sales Price by Type (2021-2026) & (US$/unit) Table 152. North America Propofol and Ciprofol Injections Sales Price by Type (2027-2032) & (US$/unit) Table 153. North America Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 154. North America Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 155. North America Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 156. North America Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 157. North America Propofol and Ciprofol Injections Sales Price by Application (2021-2026) & (US$/unit) Table 158. North America Propofol and Ciprofol Injections Sales Price by Application (2027-2032) & (US$/unit) Table 159. North America Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. North America Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. North America Propofol and Ciprofol Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. North America Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. North America Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 164. North America Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 165. North America Propofol and Ciprofol Injections Sales Price by Country (2021-2026) & (US$/unit) Table 166. North America Propofol and Ciprofol Injections Sales Price by Country (2027-2032) & (US$/unit) Table 167. United States Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 168. Canada Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 169. Mexico Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 170. Europe Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 171. Europe Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 172. Europe Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 173. Europe Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 174. Europe Propofol and Ciprofol Injections Sales Price by Type (2021-2026) & (US$/unit) Table 175. Europe Propofol and Ciprofol Injections Sales Price by Type (2027-2032) & (US$/unit) Table 176. Europe Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 177. Europe Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 178. Europe Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 179. Europe Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 180. Europe Propofol and Ciprofol Injections Sales Price by Application (2021-2026) & (US$/unit) Table 181. Europe Propofol and Ciprofol Injections Sales Price by Application (2027-2032) & (US$/unit) Table 182. Europe Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Europe Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Europe Propofol and Ciprofol Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Europe Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 186. Europe Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 187. Europe Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 188. Europe Propofol and Ciprofol Injections Sales Price by Country (2021-2026) & (US$/unit) Table 189. Europe Propofol and Ciprofol Injections Sales Price by Country (2027-2032) & (US$/unit) Table 190. Germany Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 191. France Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 192. U.K. Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 193. Italy Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 194. Russia Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 195. Spain Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 196. Netherlands Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 197. Switzerland Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 198. Sweden Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 199. Poland Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 200. China Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 201. China Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 202. China Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 203. China Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 204. China Propofol and Ciprofol Injections Sales Price by Type (2021-2026) & (US$/unit) Table 205. China Propofol and Ciprofol Injections Sales Price by Type (2027-2032) & (US$/unit) Table 206. China Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 207. China Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 208. China Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 209. China Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 210. China Propofol and Ciprofol Injections Sales Price by Application (2021-2026) & (US$/unit) Table 211. China Propofol and Ciprofol Injections Sales Price by Application (2027-2032) & (US$/unit) Table 212. Asia Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 213. Asia Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 214. Asia Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 215. Asia Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 216. Asia Propofol and Ciprofol Injections Sales Price by Type (2021-2026) & (US$/unit) Table 217. Asia Propofol and Ciprofol Injections Sales Price by Type (2027-2032) & (US$/unit) Table 218. Asia Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 219. Asia Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 220. Asia Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 221. Asia Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 222. Asia Propofol and Ciprofol Injections Sales Price by Application (2021-2026) & (US$/unit) Table 223. Asia Propofol and Ciprofol Injections Sales Price by Application (2027-2032) & (US$/unit) Table 224. Asia Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 225. Asia Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 226. Asia Propofol and Ciprofol Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 227. Asia Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 228. Asia Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 229. Asia Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 230. Asia Propofol and Ciprofol Injections Sales Price by Country (2021-2026) & (US$/unit) Table 231. Asia Propofol and Ciprofol Injections Sales Price by Country (2027-2032) & (US$/unit) Table 232. Japan Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 233. South Korea Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 234. India Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 235. Australia Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 236. Taiwan Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 237. Southeast Asia Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 238. SAMEA Propofol and Ciprofol Injections Revenue by Type (2021-2026) & (US$ Million) Table 239. SAMEA Propofol and Ciprofol Injections Revenue by Type (2027-2032) & (US$ Million) Table 240. SAMEA Propofol and Ciprofol Injections Sales by Type (2021-2026) & (k units) Table 241. SAMEA Propofol and Ciprofol Injections Sales by Type (2027-2032) & (k units) Table 242. SAMEA Propofol and Ciprofol Injections Sales Price by Type (2021-2026) & (US$/unit) Table 243. SAMEA Propofol and Ciprofol Injections Sales Price by Type (2027-2032) & (US$/unit) Table 244. SAMEA Propofol and Ciprofol Injections Revenue by Application (2021-2026) & (US$ Million) Table 245. SAMEA Propofol and Ciprofol Injections Revenue by Application (2027-2032) & (US$ Million) Table 246. SAMEA Propofol and Ciprofol Injections Sales by Application (2021-2026) & (k units) Table 247. SAMEA Propofol and Ciprofol Injections Sales by Application (2027-2032) & (k units) Table 248. SAMEA Propofol and Ciprofol Injections Sales Price by Application (2021-2026) & (US$/unit) Table 249. SAMEA Propofol and Ciprofol Injections Sales Price by Application (2027-2032) & (US$/unit) Table 250. SAMEA Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 251. SAMEA Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 252. SAMEA Propofol and Ciprofol Injections Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 253. SAMEA Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 254. SAMEA Propofol and Ciprofol Injections Sales by Country (2021-2026) & (k units) Table 255. SAMEA Propofol and Ciprofol Injections Sales by Country (2027-2032) & (k units) Table 256. SAMEA Propofol and Ciprofol Injections Sales Price by Country (2021-2026) & (US$/unit) Table 257. SAMEA Propofol and Ciprofol Injections Sales Price by Country (2027-2032) & (US$/unit) Table 258. Brazil Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 259. Argentina Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 260. Chile Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 261. Colombia Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 262. Peru Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 263. Saudi Arabia Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 264. Israel Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 265. UAE Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 266. Turkey Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 267. Iran Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 268. Egypt Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Table 269. Key Raw Materials Table 270. Raw Materials Key Suppliers Table 271. Propofol and Ciprofol Injections Distributors List Table 272. Propofol and Ciprofol Injections Customers List Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources Table 276. Primary Sources List of Figures Figure 1. Propofol and Ciprofol Injections Image Figure 2. Global Propofol and Ciprofol Injections Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol and Ciprofol Injections Market Size Share 2021 VS 2025 VS 2032 Figure 4. Propofol Injections Image Figure 5. Ciprofol Injections Image Figure 6. Global Propofol and Ciprofol Injections Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Propofol and Ciprofol Injections Market Size Share 2021 VS 2025 VS 2032 Figure 8. Gastrointestinal Endoscopy Image Figure 9. Anesthesia for Surgery Image Figure 10. Other Image Figure 11. Global Propofol and Ciprofol Injections Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Propofol and Ciprofol Injections Revenue (2021-2032) & (US$ Million) Figure 13. Global Propofol and Ciprofol Injections Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Propofol and Ciprofol Injections Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2032) Figure 16. Global Propofol and Ciprofol Injections Sales (2021-2032) & (k units) Figure 17. Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Propofol and Ciprofol Injections Sales YoY (2021-2032) & (k units) Figure 20. Europe Propofol and Ciprofol Injections Sales YoY (2021-2032) & (k units) Figure 21. China Propofol and Ciprofol Injections Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Propofol and Ciprofol Injections Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Propofol and Ciprofol Injections Sales YoY (2021-2032) & (k units) Figure 24. Global Propofol and Ciprofol Injections Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Propofol and Ciprofol Injections Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Propofol and Ciprofol Injections Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Propofol and Ciprofol Injections Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032) Figure 30. Global Propofol and Ciprofol Injections Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Propofol and Ciprofol Injections Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032) Figure 33. Global Propofol and Ciprofol Injections Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Propofol and Ciprofol Injections Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032) Figure 36. Global Propofol and Ciprofol Injections Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Propofol and Ciprofol Injections Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032) Figure 39. North America Propofol and Ciprofol Injections Revenue Share by Type (2021-2032) Figure 40. North America Propofol and Ciprofol Injections Sales Share by Type (2021-2032) Figure 41. North America Propofol and Ciprofol Injections Revenue Share by Application (2021-2032) Figure 42. North America Propofol and Ciprofol Injections Sales Share by Application (2021-2032) Figure 43. North America Propofol and Ciprofol Injections Revenue Share by Country (2021-2032) Figure 44. North America Propofol and Ciprofol Injections Sales Share by Country (2021-2032) Figure 45. Europe Propofol and Ciprofol Injections Revenue Share by Type (2021-2032) Figure 46. Europe Propofol and Ciprofol Injections Sales Share by Type (2021-2032) Figure 47. Europe Propofol and Ciprofol Injections Revenue Share by Application (2021-2032) Figure 48. Europe Propofol and Ciprofol Injections Sales Share by Application (2021-2032) Figure 49. Europe Propofol and Ciprofol Injections Revenue Share by Country (2021-2032) Figure 50. Europe Propofol and Ciprofol Injections Sales Share by Country (2021-2032) Figure 51. China Propofol and Ciprofol Injections Revenue Share by Type (2021-2032) Figure 52. China Propofol and Ciprofol Injections Sales Share by Type (2021-2032) Figure 53. China Propofol and Ciprofol Injections Revenue Share by Application (2021-2032) Figure 54. China Propofol and Ciprofol Injections Sales Share by Application (2021-2032) Figure 55. Asia Propofol and Ciprofol Injections Revenue Share by Type (2021-2032) Figure 56. Asia Propofol and Ciprofol Injections Sales Share by Type (2021-2032) Figure 57. Asia Propofol and Ciprofol Injections Revenue Share by Application (2021-2032) Figure 58. Asia Propofol and Ciprofol Injections Sales Share by Application (2021-2032) Figure 59. Asia Propofol and Ciprofol Injections Revenue Share by Country (2021-2032) Figure 60. Asia Propofol and Ciprofol Injections Sales Share by Country (2021-2032) Figure 61. SAMEA Propofol and Ciprofol Injections Revenue Share by Type (2021-2032) Figure 62. SAMEA Propofol and Ciprofol Injections Sales Share by Type (2021-2032) Figure 63. SAMEA Propofol and Ciprofol Injections Revenue Share by Application (2021-2032) Figure 64. SAMEA Propofol and Ciprofol Injections Sales Share by Application (2021-2032) Figure 65. SAMEA Propofol and Ciprofol Injections Revenue Share by Country (2021-2032) Figure 66. SAMEA Propofol and Ciprofol Injections Sales Share by Country (2021-2032) Figure 67. Propofol and Ciprofol Injections Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Propofol and Ciprofol Injections Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Propofol Injections
  • Ciprofol Injections
Applications
  • Gastrointestinal Endoscopy
  • Anesthesia for Surgery
  • Other
Companies covered
  • Xi’an Libang Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Haisco Pharmaceutical Group
  • Jiangsu Yingke Biopharmaceutical
  • Pfizer
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Jiangsu Nhwa Pharmaceutical
  • B. Braun
  • Beijing Sciecure Pharmaceutical
  • Sichuan Biokin Pharmaceutical
  • AstraZeneca
  • Wellona Pharma
  • Rusoma
  • NEON
  • Flagship Biotech
  • Dr. Reddy's Laboratories
  • Centurion Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Propofol and Ciprofol Injections Market by Type
  3. 1.2.1 Global Propofol and Ciprofol Injections Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Propofol Injections
  5. 1.2.3 Ciprofol Injections
  6. 1.3 Propofol and Ciprofol Injections Market by Application
  7. 1.3.1 Global Propofol and Ciprofol Injections Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Gastrointestinal Endoscopy
  9. 1.3.3 Anesthesia for Surgery
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Propofol and Ciprofol Injections Market Dynamics
  1. 2.1 Propofol and Ciprofol Injections Industry Trends
  2. 2.2 Propofol and Ciprofol Injections Industry Drivers
  3. 2.3 Propofol and Ciprofol Injections Industry Opportunities and Challenges
  4. 2.4 Propofol and Ciprofol Injections Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Propofol and Ciprofol Injections Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Propofol and Ciprofol Injections Revenue by Region
  3. 3.2.1 Global Propofol and Ciprofol Injections Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Propofol and Ciprofol Injections Revenue by Region (2021-2026)
  5. 3.2.3 Global Propofol and Ciprofol Injections Revenue by Region (2027-2032)
  6. 3.2.4 Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Propofol and Ciprofol Injections Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Propofol and Ciprofol Injections Sales by Region
  9. 3.4.1 Global Propofol and Ciprofol Injections Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Propofol and Ciprofol Injections Sales by Region (2021-2026)
  11. 3.4.3 Global Propofol and Ciprofol Injections Sales by Region (2027-2032)
  12. 3.4.4 Global Propofol and Ciprofol Injections Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Propofol and Ciprofol Injections Revenue by Manufacturers
  2. 4.1.1 Global Propofol and Ciprofol Injections Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Propofol and Ciprofol Injections Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Propofol and Ciprofol Injections Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Propofol and Ciprofol Injections Sales by Manufacturers
  6. 4.2.1 Global Propofol and Ciprofol Injections Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Propofol and Ciprofol Injections Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Propofol and Ciprofol Injections Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Propofol and Ciprofol Injections Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Propofol and Ciprofol Injections Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Propofol and Ciprofol Injections Manufacturers, Product Type & Application
  13. 4.7 Global Propofol and Ciprofol Injections Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Propofol and Ciprofol Injections Market CR5 and HHI
  16. 4.8.2 2025 Propofol and Ciprofol Injections Tier 1, Tier 2, and Tier 3
5 Propofol and Ciprofol Injections Market by Type
  1. 5.1 Global Propofol and Ciprofol Injections Revenue by Type
  2. 5.1.1 Global Propofol and Ciprofol Injections Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Propofol and Ciprofol Injections Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Propofol and Ciprofol Injections Sales by Type
  6. 5.2.1 Global Propofol and Ciprofol Injections Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol and Ciprofol Injections Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021-2032)
  9. 5.3 Global Propofol and Ciprofol Injections Price by Type
6 Propofol and Ciprofol Injections Market by Application
  1. 6.1 Global Propofol and Ciprofol Injections Revenue by Application
  2. 6.1.1 Global Propofol and Ciprofol Injections Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Propofol and Ciprofol Injections Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Propofol and Ciprofol Injections Sales by Application
  6. 6.2.1 Global Propofol and Ciprofol Injections Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Propofol and Ciprofol Injections Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Propofol and Ciprofol Injections Sales Market Share by Application (2021-2032)
  9. 6.3 Global Propofol and Ciprofol Injections Price by Application
7 Company Profiles
  1. 7.1 Xi’an Libang Pharmaceutical
  2. 7.1.1 Xi’an Libang Pharmaceutical Company Information
  3. 7.1.2 Xi’an Libang Pharmaceutical Business Overview
  4. 7.1.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  6. 7.1.5 Xi’an Libang Pharmaceutical Recent Developments
  7. 7.2 Sichuan Kelun Pharmaceutical
  8. 7.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 7.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 7.2.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  12. 7.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 7.3 Haisco Pharmaceutical Group
  14. 7.3.1 Haisco Pharmaceutical Group Company Information
  15. 7.3.2 Haisco Pharmaceutical Group Business Overview
  16. 7.3.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio
  18. 7.3.5 Haisco Pharmaceutical Group Recent Developments
  19. 7.4 Jiangsu Yingke Biopharmaceutical
  20. 7.4.1 Jiangsu Yingke Biopharmaceutical Company Information
  21. 7.4.2 Jiangsu Yingke Biopharmaceutical Business Overview
  22. 7.4.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio
  24. 7.4.5 Jiangsu Yingke Biopharmaceutical Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Propofol and Ciprofol Injections Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Guangdong Jiabo Pharmaceutical
  32. 7.6.1 Guangdong Jiabo Pharmaceutical Company Information
  33. 7.6.2 Guangdong Jiabo Pharmaceutical Business Overview
  34. 7.6.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  36. 7.6.5 Guangdong Jiabo Pharmaceutical Recent Developments
  37. 7.7 Fresenius Kabi
  38. 7.7.1 Fresenius Kabi Company Information
  39. 7.7.2 Fresenius Kabi Business Overview
  40. 7.7.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio
  42. 7.7.5 Fresenius Kabi Recent Developments
  43. 7.8 Jiangsu Nhwa Pharmaceutical
  44. 7.8.1 Jiangsu Nhwa Pharmaceutical Company Information
  45. 7.8.2 Jiangsu Nhwa Pharmaceutical Business Overview
  46. 7.8.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  48. 7.8.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  49. 7.9 B. Braun
  50. 7.9.1 B. Braun Company Information
  51. 7.9.2 B. Braun Business Overview
  52. 7.9.3 B. Braun Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 B. Braun Propofol and Ciprofol Injections Product Portfolio
  54. 7.9.5 B. Braun Recent Developments
  55. 7.10 Beijing Sciecure Pharmaceutical
  56. 7.10.1 Beijing Sciecure Pharmaceutical Company Information
  57. 7.10.2 Beijing Sciecure Pharmaceutical Business Overview
  58. 7.10.3 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  60. 7.10.5 Beijing Sciecure Pharmaceutical Recent Developments
  61. 7.11 Sichuan Biokin Pharmaceutical
  62. 7.11.1 Sichuan Biokin Pharmaceutical Company Information
  63. 7.11.2 Sichuan Biokin Pharmaceutical Business Overview
  64. 7.11.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio
  66. 7.11.5 Sichuan Biokin Pharmaceutical Recent Developments
  67. 7.12 AstraZeneca
  68. 7.12.1 AstraZeneca Company Information
  69. 7.12.2 AstraZeneca Business Overview
  70. 7.12.3 AstraZeneca Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 AstraZeneca Propofol and Ciprofol Injections Product Portfolio
  72. 7.12.5 AstraZeneca Recent Developments
  73. 7.13 Wellona Pharma
  74. 7.13.1 Wellona Pharma Company Information
  75. 7.13.2 Wellona Pharma Business Overview
  76. 7.13.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Wellona Pharma Propofol and Ciprofol Injections Product Portfolio
  78. 7.13.5 Wellona Pharma Recent Developments
  79. 7.14 Rusoma
  80. 7.14.1 Rusoma Company Information
  81. 7.14.2 Rusoma Business Overview
  82. 7.14.3 Rusoma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Rusoma Propofol and Ciprofol Injections Product Portfolio
  84. 7.14.5 Rusoma Recent Developments
  85. 7.15 NEON
  86. 7.15.1 NEON Company Information
  87. 7.15.2 NEON Business Overview
  88. 7.15.3 NEON Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 NEON Propofol and Ciprofol Injections Product Portfolio
  90. 7.15.5 NEON Recent Developments
  91. 7.16 Flagship Biotech
  92. 7.16.1 Flagship Biotech Company Information
  93. 7.16.2 Flagship Biotech Business Overview
  94. 7.16.3 Flagship Biotech Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Flagship Biotech Propofol and Ciprofol Injections Product Portfolio
  96. 7.16.5 Flagship Biotech Recent Developments
  97. 7.17 Dr. Reddy's Laboratories
  98. 7.17.1 Dr. Reddy's Laboratories Company Information
  99. 7.17.2 Dr. Reddy's Laboratories Business Overview
  100. 7.17.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio
  102. 7.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 7.18 Centurion Healthcare
  104. 7.18.1 Centurion Healthcare Company Information
  105. 7.18.2 Centurion Healthcare Business Overview
  106. 7.18.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio
  108. 7.18.5 Centurion Healthcare Recent Developments
8 North America
  1. 8.1 North America Propofol and Ciprofol Injections Market Size by Type
  2. 8.1.1 North America Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  3. 8.1.2 North America Propofol and Ciprofol Injections Sales by Type (2021-2032)
  4. 8.1.3 North America Propofol and Ciprofol Injections Price by Type (2021-2032)
  5. 8.2 North America Propofol and Ciprofol Injections Market Size by Application
  6. 8.2.1 North America Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  7. 8.2.2 North America Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 8.2.3 North America Propofol and Ciprofol Injections Price by Application (2021-2032)
  9. 8.3 North America Propofol and Ciprofol Injections Market Size by Country
  10. 8.3.1 North America Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Propofol and Ciprofol Injections Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Propofol and Ciprofol Injections Market Size by Type
  2. 9.1.1 Europe Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  3. 9.1.2 Europe Propofol and Ciprofol Injections Sales by Type (2021-2032)
  4. 9.1.3 Europe Propofol and Ciprofol Injections Price by Type (2021-2032)
  5. 9.2 Europe Propofol and Ciprofol Injections Market Size by Application
  6. 9.2.1 Europe Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  7. 9.2.2 Europe Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 9.2.3 Europe Propofol and Ciprofol Injections Price by Application (2021-2032)
  9. 9.3 Europe Propofol and Ciprofol Injections Market Size by Country
  10. 9.3.1 Europe Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Propofol and Ciprofol Injections Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Propofol and Ciprofol Injections Market Size by Type
  2. 10.1.1 China Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  3. 10.1.2 China Propofol and Ciprofol Injections Sales by Type (2021-2032)
  4. 10.1.3 China Propofol and Ciprofol Injections Price by Type (2021-2032)
  5. 10.2 China Propofol and Ciprofol Injections Market Size by Application
  6. 10.2.1 China Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  7. 10.2.2 China Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 10.2.3 China Propofol and Ciprofol Injections Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Propofol and Ciprofol Injections Market Size by Type
  2. 11.1.1 Asia Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  3. 11.1.2 Asia Propofol and Ciprofol Injections Sales by Type (2021-2032)
  4. 11.1.3 Asia Propofol and Ciprofol Injections Price by Type (2021-2032)
  5. 11.2 Asia Propofol and Ciprofol Injections Market Size by Application
  6. 11.2.1 Asia Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  7. 11.2.2 Asia Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 11.2.3 Asia Propofol and Ciprofol Injections Price by Application (2021-2032)
  9. 11.3 Asia Propofol and Ciprofol Injections Market Size by Country
  10. 11.3.1 Asia Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Propofol and Ciprofol Injections Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Propofol and Ciprofol Injections Market Size by Type
  2. 12.1.1 SAMEA Propofol and Ciprofol Injections Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Propofol and Ciprofol Injections Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Propofol and Ciprofol Injections Price by Type (2021-2032)
  5. 12.2 SAMEA Propofol and Ciprofol Injections Market Size by Application
  6. 12.2.1 SAMEA Propofol and Ciprofol Injections Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Propofol and Ciprofol Injections Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Propofol and Ciprofol Injections Price by Application (2021-2032)
  9. 12.3 SAMEA Propofol and Ciprofol Injections Market Size by Country
  10. 12.3.1 SAMEA Propofol and Ciprofol Injections Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Propofol and Ciprofol Injections Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Propofol and Ciprofol Injections Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Propofol and Ciprofol Injections Value Chain Analysis
  2. 13.1.1 Propofol and Ciprofol Injections Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Propofol and Ciprofol Injections Production Mode & Process
  6. 13.2 Propofol and Ciprofol Injections Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Propofol and Ciprofol Injections Distributors
  9. 13.2.3 Propofol and Ciprofol Injections Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst